Overview

Guilford Pharmaceuticals Inc. is a biotechnology company focused on the development of innovative therapies for central nervous system disorders. It operates as a subsidiary of a larger pharmaceutical entity.

Therapeutic areas

API / Drug Master Files

Guilford Pharmaceuticals Inc. holds 0 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • P(DAPG-EOP)Inactive1998-04-21
  • GPI 202Inactive1998-03-31

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Guilford Pharmaceuticals Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.